Urinary and erectile dysfunction in Multiple System Atrophy (MSA)

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3132342 12 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Urinary and erectile dysfunction in Multiple System Atrophy (MSA)
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Multiple system atrophy (MSA) is a neurodegenerative disease of undetermined etiology that occurs sporadically and manifests itself as a combination of parkinsonian, autonomic, cerebellar, and pyramidal signs. Despite the lack of effective therapies, some of the symptoms may be, at least temporarily, improved with adequate symptomatic therapies. Urinary and erectile dysfunction (ED) symptoms are prominent early features in male MSA patients. Lower urinary tract infections (UTIs) are a major cause of morbidity and mortality in this disorder. More than 50% of MSA patients suffer from recurrent lower UTIs and a significant number (∼25%) die of complications related to them. Urogenital symptoms in MSA are usually due to a complex mixture of central and peripheral nervous abnormalities, sometimes superimposed on previous local pathological conditions such as benign prostatic hyperplasia and perineal laxity. There have been instances were MSA-related urological symptoms were confused with symptoms of benign prostatic hyperplasia, leading to unnecessary urological surgery. In this review, we present the phenotypic range and therapeutic approaches for common storage and voiding urological symptoms and ED, in patients with MSA. © 2007 Wiley-Liss, Inc.
Έτος δημοσίευσης:
2008
Συγγραφείς:
Papatsoris, A.G.
Papapetropoulos, S.
Singer, C.
Deliveliotis, C.
Περιοδικό:
Neurourology and Urodynamics
Τόμος:
27
Αριθμός / τεύχος:
1
Σελίδες:
22-27
Λέξεις-κλειδιά:
alpha adrenergic receptor blocking agent; apomorphine; cholinergic receptor blocking agent; cholinergic receptor stimulating agent; oxybutynin; phosphodiesterase V inhibitor; prazosin; propiverine; sildenafil; tadalafil; tamsulosin; tolterodine; vardenafil, algorithm; autonomic dysfunction; bladder catheterization; cerebellum disease; clinical assessment; degenerative disease; detrusor dyssynergia; disease association; erectile dysfunction; human; intermittent catheterization; morbidity; mortality; overactive bladder; parkinsonism; penis erection; peripheral neuropathy; phenotype; postvoid residual urine volume; prostate hypertrophy; pyramidal sign; review; Shy Drager syndrome; side effect; sphincterotomy; transurethral resection; urinary dysfunction; urinary tract infection; urogenital tract disease, Erectile Dysfunction; Humans; Male; Multiple System Atrophy; Phenotype; Urinary Tract; Urinary Tract Infections; Urination Disorders
Επίσημο URL (Εκδότης):
DOI:
10.1002/nau.20461
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.